2-(Dimethyl-1,2-oxazol-4-yl)acetic acid → ((7R)-7-{[2-(3,5-Dimethyl-isoxazol-4-yl)-acetyl]-methyl-amino}-6,7,8,9-tetrahydro-pyrido[1,2-a]indol-10-yl)-acetic acid
Reaktionsgleichung
[CH3:1][C:2]1[C:6]([CH2:7][C:8]([OH:10])=O)=[C:5]([CH3:11])[O:4][N:3]=1.[CH3:12][NH:13][C@H:14]1[CH2:33][N:18]2[C:19]3[C:24]([C:25]([CH2:26][C:27]([O:29]CCC)=[O:28])=[C:17]2[CH2:16][CH2:15]1)=[CH:23][CH:22]=[CH:21][CH:20]=3>>[CH3:1][C:2]1[C:6]([CH2:7][C:8]([N:13]([CH3:12])[C@H:14]2[CH2:33][N:18]3[C:19]4[C:24]([C:25]([CH2:26][C:27]([OH:29])=[O:28])=[C:17]3[CH2:16][CH2:15]2)=[CH:23][CH:22]=[CH:21][CH:20]=4)=[O:10])=[C:5]([CH3:11])[O:4][N:3]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared using analogous procedures described in Example 1 (Method A) from (3,5-dimethylisoxazol-4-yl)acetic acid and propyl [(7R)-7-(methylamino)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetate. MS (+ESI) m/z: 396.
Quellen und Nachweise
- ORD-Eintrag